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Abstract
Objectives—Long-chain omega-3 polyunsaturated fatty acids (LCω3PUFAs), selenium (Se) and
mercury (Hg) are three important components in fish. The cardioprotective effect of LCω3PUFA
intake has been recognized; however, the hypothesis that this benefit may be greatest with high Se
and low Hg levels has not been investigated.
Design—A cohort of 4,508 American adults aged 18–30, without hypertension at baseline in
1985, were enrolled. Six follow-ups were conducted at exams in 1987, 1990, 1992, 1995, 2000
and 2005. Diet was assessed by a validated interviewer-administered quantitative food frequency
questionnaire at exams in 1985, 1992 and 2005. Incident hypertension was defined as first
occurrence at any follow-up examination of systolic blood pressure ≥ 140 mmHg, diastolic blood
pressure ≥ 90 mmHg, or taking anti-hypertensive medication. Toenail clippings were collected in
1987, and Se and Hg levels were quantified by instrumental neutron-activation analysis.
Result—Participants in the highest LCω3PUFAintake quartile had a significantly lower
incidence of hypertension (Hazard Ratio: 0.65; 95% CI: 0.53–0.79; Ptrend<0.01) compared to those
in the lowest quartile after adjustment for potential confounders. Docosahexaenoic acid showed a
greater inverse association than eicosapentaenoic acid. The inverse association of LCω3PUFA
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intake with hypertension appeared more pronounced at higher Se and lower Hg levels, although
interaction tests were statistically non-significant.
Conclusions—Out findings indicated that LCω3PUFA intake was inversely associated with
incidence of hypertension. The prior hypothesis that the potential anti-hypertensive effect of
LCω3PUFA intake varies depending on joint levels of Se and Hg received modest support, and
cannot be ruled out.
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Introduction
Fish or seafood is the major dietary source of long-chain omega-3 polyunsaturated fatty
acids (LCω3PUFAs), including eicosapentaenoic acid (EPA, 20:5 ω-3), docosapentaenoic
acid (DPA, 22:5 ω-3) and docosahexaenoic acid (DHA, 22:6 ω-3). Arobust body of
evidence supports that fish consumption or LCω3PUFAintake may have a beneficial effect
on cardiovascular disease (CVD) risk, particularly, fatal coronary heart disease (CHD).[1–5]
One of the postulated mechanisms underlying this potential benefit is that LCω3PUFA
intake may favorably modify blood pressure (BP),[6] a major CVD risk factor.[7–
8]Although the literature is not quite consistent, the majority of experimental and
epidemiological studies have suggested that LCω3PUFAs at high dose could lower BP.[9–
10]A meta-analysis published in 1993 summarized 31 placebo-controlled clinical trials
including a total of 1,356 individuals and found both EPA and DHA can significantly reduce
BP in a dose-response fashion in hypertensive patients though not in normotensive
individuals.[11] The findings were confirmed by two other meta-analyses of clinical trials.
[12–13] However, data on the association of usual dietary intake of LCω3PUFA with BP
and incidence of hypertension are sparse.
While fish consumption has consistently increased over the past decades, concerns have
been raised regarding potential harm of exposure to mercury (Hg) found in some fish. In
addition to its potential neurotoxicity,[14] Hg ingestion from fish has been linked to
increased risk of CHD in men,[15–16] as well as to high BP among Nunavik Inuit adults in
a recent study.[10] On the other hand, fish is rich in selenium (Se), an antioxidant that may
provide cardioprotective benefits by itself at an optimal level or by interacting with
LCω3PUFA intake.[17] Notably, Se may moderate the toxic effects of Hg in the body.[18]
Thus, it is important to consider both Hg and Se in addition to LCω3PUFAs when
investigating the potential beneficial effects of fish consumption. Recently, a hypothesis has
been proposed that Se and Hg may jointly modify the association between LCω3PUFAs and
CVD risk, with the greatest benefit expected in the setting of high Se and low Hg
concentrations.[4] We therefore prospectively examined intakes of LCω3PUFAs and fish in
relation to incidence of hypertension, and investigated the possible modifications of Se and
Hg on the associations between LCω3PUFAs and hypertension using data from the
Coronary Artery Risk Development in Young Adults (CARDIA) Study.
Methods
Study Population
CARDIA is an ongoing, multi-center, prospective cohort study designed to examine
physiological, psychological and other lifestyle factors that might affect evolution of CVD
risk among American young adults. Details of the study design have been published
elsewhere.[19] Briefly, at baseline in 1985, 5,115 men and women, aged 18 to 30 years,
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were enrolled from four US cities including Birmingham, Alabama; Chicago, Illinois;
Minneapolis, Minnesota; and Oakland, California. By design, this cohort was roughly
balanced by age (18–24 and 25–30), gender, ethnicity(AfricanAmerican and Caucasian), and
education (high school or below and beyond high school). To date, six follow-up
examinations have been conducted at exam years 2, 5, 7, 10, 15 and 20. Follow-up rates
averaged greater than 90% and approximately 70% of the participants in the original cohort
returned at year 20. We excluded participants who reported implausible total energy intake
(<800 or >8000 kcal/d for men, and <600 or >6000 kcal/d for women) (n=46) and
participants with missing data on exposure variables at all diet assessments (n=4). To be
conservative, we also excluded pregnant women at any examination (n=237). A total of
4,828 participants remained in the analyses of LCω3PUFA or non-fried fish in relation to
blood pressure. To examine the association between LCω3PUFAand non-fried fish and
incidence of hypertension, we further excluded participants who had diagnosed hypertension
at baseline (n=140), who had no information for defining incident hypertension during the
follow-up (n=175) and had incomplete exposure information for creating cumulative diet
model in the analysis (n=5).[20] After all these exclusions, 4,508 participants remained in
the analyses. Of these, 3,883 participants with both toenail Se and Hg data available were
included in the analyses investigating effect modification of Se and Hg on the association of
LCω3PUFA intake and incident hypertension.
All participants gave informed consent. The study design, data collection, and analyses were
approved by the institutional review boards of the participating institutions.
Ascertainment of fish consumption and LCω3PUFA intake
The CARDIA Diet History questionnaire, an interviewer-administered quantitative food
frequency questionnaire (FFQ), was designed to assess habitual eating patterns. The validity
and reproducibility of CARDIA FFQ has been evaluated and discussed elsewhere.[21–22]
Diet assessment was conducted three times at baseline, exam years 7 and 20. Participants
were asked to recall their usual dietary intakes by using the previous 30 days as the time
frame. They were asked general questions about their diet, which elicited specific foods
consumed in an open-ended fashion. They were then asked to report the frequency, amount,
and method of food preparation for each food named. Particularly for fish consumption,
participants were asked: 1) “Do you eat any fresh, frozen, or smoked fish? Include any sushi
or fast food fish sandwiches eaten at places such as McDonald’s, Burger King, or
Wendy’s.”; 2) “Do you eat any fresh or frozen shellfish, octopus, or squid?”; 3) “Do you eat
tuna salad?”; and 4) “Do you eat any other canned fish including tuna, sardines, herring, or
salmon?”. In addition, studies have suggested that the preparation method, particularly
frying, may substantially alter the fatty acid content of a fish meal.[23] Consequently, the
association with CVD risk may be different.[24] Therefore, we divided fish consumption
into fried fish and non-fried fish. Fried fish included fried fish and fried shellfish from
commercial and fast food.[25] Non-fried fish was the sum of fresh fish, smoked fish, lean
fish and shellfish. Because the distribution of fried fish consumption was extremely skewed
and relatively narrow, we did not treat fried fish as an exposure of interest. Instead, we
adjusted for fried fish when examining non-fried fish. Similarly, we did not separate
shellfish from other fish in the primary analysis. However, we excluded shellfish in a
sensitivity analysis. In addition, we were not able to single fish in fast food out based on the
available information from the questionnaire.
Nutrient intake was estimated using an adaptively updated nutrient database from Nutrition
Coordinating Center at the University of Minnesota. This database is a food composition
table containing 1609 distinct codes for exam years 0 and 7, and over 7000 codes for exam
year 20, including LCω3PUFAs. In this study, LCω3PUFA intake was defined as the sum of
Xun et al. Page 3













DHA, EPAand DPA. Because of the relatively small amount and the narrow distribution,
DPA was not analyzed as a separate exposure in this study.
Ascertainment of hypertension
BP was measured using the Hawksley random-zero (RZ) sphygmomanometer (W. A. Baum
Co, Copiague, New York) in the first six examinations (i.e. exam years 0, 2, 5, 7, 10 and 15)
and the OmROn HEM907XL at exam year 20 by trained and certified technicians.[26] Each
participant had three BP measurements taken from the right arm at 1-minute intervals after a
5-minute seated rest. The second and third of the three measurements were averaged for
analyses. Systolic blood pressure (SBP) and diastolic blood pressure (DBP) were recorded
as phase I and V Korotkoff sounds through year 15. Based on a study in 900 participants, at
exam year 20 we estimated systolic BP (RZ) =3.74+0.96 * observed OmROn systolic BP
and estimated diastolic BP =1.30+0.97 * observed OmROn diastolic BP.
The hypertension endpoint is based on BP cutoff points used in the seventh report of the
Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure.
[27] Incident hypertension was defined as first occurrence at any follow-up examination of
SBP ≥ 140 mm Hg or DBP ≥ 90 mm Hg or if taking anti-hypertensive medication.
Ascertainment of toenail Se and Hg
Toenail clippings were collected with a stainless steel clipper from all 10 toes by the
participants themselves at exam year 2. All toenail clippings were processed with a washing
procedure in a sonicator with deionized water.[28]The levels of Se and Hg were analyzed by
instrumental neutron-activation analysis at the University of Missouri Research Reactor.[29]
Toenail specimens were treated in random order by the laboratory personnel who were
blinded to other clinical measures. The average coefficient of variation in duplicate toenail
sub-samples was 2.5% for Se and 6.8% for Hg in the present study.
Toenail Se is recognized as the best available reliable biomarker reflecting relatively long-
term Se intake.[30–32]Asingle sample of the toenail concentration of Se represents exposure
over 9 to 12 months.[33–34] Similarly, Hg level in toenail provides the best biomarker of
long-term Hg exposure.[35–36] Spearman correlation coefficients for the reproducibility of
toenail levels of Se and Hg were 0.48 and 0.54, respectively, over 6 years.[37] In a pilot
study conducted in 2007 among 64 randomly selected CARDIA participants from the
Chicago Study Center, the Spearman correlation coefficient between two measurements of
toenail concentrations collected 20 years apart by the same laboratory with the same
protocol was 0.56 (Se) and 0.60 (Hg).[28]
Ascertainment of covariates
Demographic variables, including age, gender, ethnicity and education level, were collected
through self-administered questionnaire and were verified during clinic examinations.
Smoking status was determined based on self-report and participants were classified into
three groups: non-smokers, former smokers and current smokers. Alcohol consumption was
measured by validated questionnaire and classified into six groups according to total daily
intake: 0 (never drink), 0.1–4.9, 5.0–9.9, 10–14.9, 15.0–19.9, and ≥ 20 g/d. Body weight and
height were measured in light clothes without shoes, during the clinical visit for each
examination. Physical activity was assessed using the CARDIA Physical Activity History
Questionnaire (PAHQ), an interviewer-administered self-report of frequency of participation
in 13 categories of recreational sports, exercise, leisure, and occupational activities over the
previous 12 months. The physical activity score was calculated in exercise units (EU)
reflecting the frequency and duration of activity over the previous year. A score of 100 EU
Xun et al. Page 4













is roughly equivalent to participation in a vigorous activity, 2 to 3 hours per week for 6
months of the year.[38–40]
Statistical Analysis
Analysis of variance, the Kruskal-Wallis test or the chi-squared test, when appropriate, was
used to compare baseline characteristics of the study population according to quartiles of
LCω3PUFA intake. Generalized estimating equations (GEEs) with identity linkage under
exchangeable correlation structure assumption were used to examine intakes of LCω3PUFA
and non-fried fish in relation to SBP and DBP. Cox proportional hazards regression model
was used to examine intakes of total LCω3PUFA, DHA, EPA and non-fried fish in relation
to incidence of hypertension.
To reduce measurement errors caused by within-person variation and to best represent the
long-term dietary intakes, we used cumulative intakes of nutrients or foods in Cox models.
[20] For example, we related fish consumption reported at baseline to the new cases
identified at exam years 2 and 5; the average of fish consumption reported at baseline and
year 7 to the new cases identified at exam years 7, 10 and 15; and the average of fish
consumption reported at baseline, years 7 and 20 to the new cases identified at year 20. We
categorized the exposure of interest into quartiles based on their distributions. We used a
sequential covariates-adjusted strategy in both GEEs and Cox models: Model 1 adjustment
for age, gender, ethnicity, and study center; Model 2 additional adjustment for body mass
index (BMI), education, smoking status, alcohol consumption, physical activity, family
history of hypertension, and dietary intakes of total energy, sodium, α-linolenic acid and
linoleic-acid. Since information on anti-hypertensive medication was used to define incident
cases of hypertension, we did not include anti-hypertensive medication in the Cox model,
but it was additionally adjusted in model 2 for the GEE analyses. When studying non-fried
fish, we further adjusted for fried fish consumption based on model 2. To examine
interaction between gender or ethnicityand intakes of LCω3PUFAs or non-fried fish, we
included corresponding interaction terms in the models followed by likelihood ratio test.
To examine the potential effect modification of Se or Hg levels on the association between
LCω3PUFA intake and incidence of hypertension, we divided toenail Se or Hg levels into
tertiles and examined the association of LCω3PUFA intake with hypertension across tertiles
using Cox proportional hazards models. We also used restricted cubic splines to study the
smoothed functions to detect any possible interaction. To make the graphs more stable, we
deleted the observations with LCω3PUFA intake above 95th percentile, which were
extremely high.[41–42]Although tests for interactions were statistically non-significant, we
conducted and presented stratified analyses in relation to our strong prior hypothesis.
To further determine the joint modification of Se and Hg levels on the association between
LCω3PUFA intake and incidence of hypertension, we divided participants into four sub-
groups defined by joint levels of median Se (0.84 μg/g) and median Hg (0.21 μg/g). The
associations were examined in each sub-group. We also used the likelihood ratio test to
determine any possible significant 2- or 3-way interaction among LCω3PUFA intake, Se
levels, and Hg levels.
All analyses were performed by using SAS version 9.1.3 (SAS Institute Inc, Cary, North
Carolina, US) and all graphics were generated using STATA 11.0 (StataCorp LP, College
Station, Texas, US). P≤0.05 was considered statistically significant.
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Table 1 displays baseline characteristics of 4,508 participants according to quartiles of
LCω3PUFA intake. The average intakes of LCω3PUFAs were 0.03, 0.09, 0.15 and 0.37 g/
day across quartiles. Comparing to participants in the lowest quartile of LCω3PUFA intake,
those in the highest quartile were slightly older, more likely to be males and African-
Americans, and had relatively higher education level and higher alcohol consumption. They
were more likely to be active and were less likely to be current smokers.
Using GEE, we found that LCω3PUFAintake was inversely associated with SBP as well as
DBP. The multivariable-adjusted β coefficients comparing the highest to the lowest quartiles
of LCω3PUFAintake were −0.92 mmHg (95% CI: −1.49 to −0.34 mmHg; P for trend <
0.01) and −0.72 mmHg (95%CI: −1.19 to −0.25 mmHg; P for trend = 0.01) for SBP and
DBP, respectively. However, non-fried fish consumption was only found to be significantly
inversely related to SBP [−0.63 (95%CI: −1.20 to −0.06; P for trend = 0.04)], not DBP
[−0.17 (95%CI: −0.65 to 0.31; P for trend = 0.63)], comparing the participants in the highest
to those in the lowest quartile. When we examined the associations among normotensive
individuals, LCω3PUFA intake, but not non-fried fish consumption, was inversely
associated with SBP and DBP.
A total of 999 new cases of hypertension occurred during the follow-up. Using Cox models,
we found that LCω3PUFAintake was inversely associated with incidence of hypertension.
Participants in the highest quartile of LCω3PUFA intake had a significantly lower incidence
of hypertension [Hazard Ratio (HR) =0.65; 95% CI: 0.53-0.79; P for trend < 0.01] compared
to those in the lowest quartile after adjustment for potential dietary and non-dietary
confounders (Table 2). The observed inverse associations between LCω3PUFAintake and
incidence of hypertension were generally consistent in each gender or ethnicityspecific
subgroup (data not shown). When examining EPA and DHAseparately, we found that DHA
had a greater inverse association with incidence of hypertension than EPA. Non-fried fish
consumption was marginally and inversely related to incidence of hypertension. Comparing
the highest to the lowest quartile of non-fried fish consumption, HR was 0.85 (95% CI:
0.70–1.03; P for trend = 0.06] (Table 2). In addition, outcome associations with total fish
with no adjustment for use of fried fish were attenuated compared to those for non-fried fish
with adjustment for fried fish (data not shown).
To test the prior hypothesis regarding the effect modifications of Se and Hg on LCω3PUFA,
we first used restricted cubic splines to detect any possible interaction by obtaining a smooth
representation of the HR as a function of LCω3PUFA intake by Se or Hg levels (tertiles)
with adjustment for the potential confounders (Figure). By visual inspection, the inverse
association between LCω3PUFAintake and incidence of hypertension was strengthened in
the highest level of Se, though the test for interaction was non-significant (P = 0.20).
However, Hg level, without reference to Se level, did not appreciably modify the inverse
association of LCω3PUFA intake with hypertension. We further considered the joint
modification of Se and Hg on LCω3PUFA intake, a 3-way interaction. We jointly classified
data according to median levels of Se (0.84 μg/g) and Hg (0.21 μg/g). The inverse
association between LCω3PUFA intake and incidence of hypertension was more
pronounced at higher Se and lower Hg levels (Table 3), though the 3-way interaction was
statistically non-significant (P = 0.57). Of note, the inverse associations were substantially
attenuated and became statistically non-significant, when Se level was below the median and
Hg level was above the median. In addition, Hg levels did not modify the association when
Se level was above the median level. The incidence of hypertension was similar between
participants with Hg levels above and below the median (0.21 μg/g) when toenail Se levels
were greater than 0.84 μg/g. Several sensitivity analyses were conducted to test the
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robustness of our findings. First, when we chose not to update diet information for incident
cases on anti-hypertensive medications at exam years 7 and 20, the results essentially were
unchanged, and p for interaction of Se and LCω3PUFA intake was 0.17 and p for three way
interaction was 0.55. Second, when we further excluded participants who had diagnosed
hypertension at year 2 when toenail Se and Hg were measured, the results remained. Third,
since most clinical trials found blood pressure reduction in a short time period after fish oil
supplementation, we used the most-recent LCω3PUFA intake in the analysis,[20] the
inverse association between LCω3PUFA intake and hypertension remained. However, the
interaction of Se and LCω3PUFA intake became statistically significant (P=0.04), with a
pattern similar to that shown in Table 3. Fourth, when we excluded shellfish from the fish
consumption, our findings were generally consistent. Fifth, when we further adjusted for
other nutrients (e.g. dietary potassium, calcium, magnesium, folic acid, saturated fat), the
findings were not appreciably altered. Finally, we considered some time-dependent
covariates (e.g. BMI, smoking status) in the models; the results were again not materially
changed.
Discussion
In this unique 20-year follow-up longitudinal prospective study, we found that LCω3PUFA
intake and non-fried fish consumption were inversely associated with BP and the incidence
of hypertension among American young adults. DHA showed a greater inverse association
with BP and incidence of hypertension than EPA. The potential favorable effect of
LCω3PUFA intake on hypertension development appeared more pronounced at higher Se
and lower Hg levels. An additional advantage is that both Se and Hg were measured in
toenails, recognized as reliable biomarkers of long-term exposure.[15,35,43–44] Moreover,
we have multiple in-depth dietary measurements. Further more, we had information to
distinguish non-fried fish from fried fish, which contributes important additional information
to the literature since the impact of different cooking methods on the effect of fish
consumption has not been well investigated.[45]
Our findings are concordant with results from previous studies.[8,46] For example, a cross-
sectional study found that dietary LCω3PUFAintake was inversely related to BP among
non-hypertensive individuals.[47]A meta-regression analysis published in 2002 included 36
randomized placebo-controlled trials, 22 of which had a double-blinded design, also showed
an anti-hypertensive effect of fish oil[13]. Two meta-analyses of clinical trials published in
1993 reported that LCω3PUFAcan significantly reduce BP.[11–12] In short, our data are
qualitatively and quantitatively similar in indicating a beneficial effect of LCω3PUFAs on
BP and incidence of hypertension. Also, our study found that compared to EPA, DHA may
provide a greater beneficial effect on hypertension, and the finding was supported by the
literature.[48–50] In addition, few studies considered how fish was prepared before
consumption. Cooking methods may alter quantities of LCω3PUFA in fish thus modifying
the potential benefits of fish consumption. Our study found a potential benefit of non-fried
fish consumption on incidence of hypertension, which was consistent with the results from
previous studies.[51–52]
Literature regarding the interaction of Se and LCω3PUFA in relation to BP levels is limited.
A randomized, double-blind study showed an interaction between LCω3PUFAand Se in
affecting the plasma concentrations of lipid peroxidationproducts,[53] indicating that high
Se levels may improve the benefit of LCω3PUFA, which is in agreement with our findings
that the inverse association between LCω3PUFA intake and incidence of hypertension was
more pronounced at high Se levels. Of note, it has been recently hypothesized that Se at very
high level may not be beneficial.[54–55] However, the optimal ranges of Se level measured
by different biomarkers such as levels in nails have not been established.
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Data on Hg and LCω3PUFA interaction are not consistent. A cross-sectional analysis of
NHANES (1999–2000) found a positive association of Hg with systolic BP only among
non-fish consumers, but did not find an overall significant association, which support the
hypothesis that the intake of fish oils may attenuate the harmful effects of Hg on BP
regulation.[56]A case-control study including participants from eight European countries
and Israel reported that high Hg content might diminish the cardioprotective effect of fish
intake”.[15] In the Kuopio Ischaemic Heart Disease (KIHD) risk factor study, the
investigators found that high Hg content measured in hair attenuated the protective effects of
LCω3PUFA intake on acute coronary events[57] and overall cardiovascular health.[16]
However, a nested case-control study found no association between toenail Hg and risk of
CHD, either before or after adjustment for age and other risk factors, including LCω3PUFA
intake.[35] In the present study, the pattern of findings was that high Hg level tended to
attenuate the anti-hypertensive effect of LCω3PUFAto some extent when Se level was low,
though the three-way interaction was statistically non-significant. Of note, the anti-
hypertensive effect of LCω3PUFA intake did not appear to be appreciably attenuated by
high level of Hg when Se level was relatively high. If this pattern is borne out, this pattern of
findings would indicate that Se could antagonize the toxicity of Hg. The first report on the
protective effect of Se against Hg’s toxicity appeared in 1967.[58]Today, the ability of Se
compounds to decrease the toxic action of Hg has been established in vitro and in animal
studies.[59–61] Epidemiological studies indicate a possible benefit of Se intake on Hg’s
cardiovascular toxicity.[62] However, Se was not found to be an effect modifier of the
relations between Hg and CHD events in the prospective study that directly evaluated the
potential interaction of Hg and Se.[35] Further studies are warranted.
To the best of our knowledge, no study has investigated three-way interactions of Se, Hg
and LCω3PUFA in relation to incidence of hypertension. A recent cross-sectional study
evaluated the influences of levels of LCω3PUFAs and Se on the association between Hg
levels and BP among Nunavik Inuit adults.[10]. The investigators found that LCω3PUFAs
and Se were strong confounders in the association between Hg and BP, but were not effect
modifiers. In the present study, we observed a pattern in which toenail Se levels modified
the inverse associations between LCω3PUFAs and hypertension. Although the tests for
interactions were statistically non-significant, the possibility of joint modification of Se and
Hg on the benefits of LCω3PUFA intake can not be excluded. The non-significant
interaction might partly be explained by sample size limitation.
The potential anti-hypertensive effect of LCω3PUFAs may not be a mono-component
action, but may involve multiple mechanisms.[63–64] LCω3PUFAs may improve vascular
and endothelial functions, as well as increase arterial compliance, thus influencing BP.[65–
66] Also, several studies indicate that LCω3PUFAs reduce heart rate and cardiac function,
which may also be associated with the anti-hypertensive effects.[49,67–68] Other possible
mechanisms include influencing sympathetic activityand enhancing endothelial nitric oxide
synthesis through hemodynamic changes.[63]
The possible mechanisms explaining the modification of Se and Hg on the anti-hypertensive
effect of LCω3PUFAs may lie in that both Se and Hg are somehow involved in the process
of oxidative stress and cardiac function through the same pathway by which LCω3PUFAs
regulate BP. In addition, studies suggest that Se can readily bind Hg to form insoluble HgSe
adducts,[69–70] prevent selenoenzyme activities from Hg-dependent inhibition, and thus
protect against Hg toxicity.[70–73]
Study limitations
A few limitations of this study also need to be considered. 1) Although the study is
observational, our studyis so far the only large-scale prospective data available on
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examining the joint modification of Se and Hg measured with biomarkers on the
longitudinal association of LCω3PUFAintake with incidence of hypertension. 2) The toenail
Se and Hg were measured at exam year 2 (1987), but not at baseline. However, this short
timeframe difference is unlikely to substantially bias our findings since toenail Se and Hg
reflect a long-term exposure and toenail Se and Hg levels are usually not materially altered
in a year or so.[34] In fact, after we further excluded participants who had diagnosed
hypertension at year 2, the results remained. Further, toenail Se and Hg were only used as
effect modifiers in the analyses. 3) More objective measures for LCω3PUFAs such as
measurement in erythrocyte cell membrane in the whole cohort were unavailable. Of note,
studies suggest that the correlation of dietary LCω3PUFAs with the concentrations in
erythrocyte cell membrane and adipose tissue are reasonably high (Spearman correlation =
0.42 for erythrocyte cell membrane and 0.40 for adipose tissue).[74–75]Although
measurement error is inevitable, the dietary measurements of LCω3PUFA intake and fish
consumption should enable us to rank participants and estimate the relative risks.Also, the
diet measurement errors are likely to be random and may bias the results towards null. 4) In
this cohort, Hg levels were relatively low compared to other populations where Hg levels
were also measured in toenails,[15,35,76] which might partially explain the null findings
when considering Hg as an effect modifier in the stratified analysis. Finally, the
generalizability of our findings may be limited. All participants were young American adults
mainly from four metropolitan areas with roughly balanced gender and ethnicity. Their
characteristics including toenail Se and Hg status may be different from the general
population.
Conclusions
Our findings indicate that LCω3PUFA intake or non-fried fish consumption is inversely
associated with BP and the incidence of hypertension, and that the potential beneficial effect
of LCω3PUFA intake on hypertension development may be more pronounced at higher Se
and lower Hg levels. The results of the present longitudinal study on an apparently healthy
American young adult population help us to better understand the benefits and risks of
consuming fish as a package containing various nutrients and contaminants. In addition,
information generated from this study may be useful for informing healthy food selection
and formulating dietary recommendations on fish consumption with respect to hypertension
prevention. The present study illustrates the need for fully considering of fish type and
preparation method, both contributing to varying levels of LCω3PUFA, Se, Hg and other
components. Additional studies are warranted to elucidate the complex interactions among
Se, Hg and LCω3PUFA, three important components in fish, in terms of hypertension
prevention.
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Modification by toenail Se or Hg levels (tertiles) of the association between LCω3PUFA
intake and incidence of hypertension (n=3883), CARDIA Study, 1985–2005. In the Cox
proportional hazards models, LCω3PUFA intake was modeled as restricted cubic splines
with nodes at the 25th, 50th, and 75th percentiles after deleting the observations above 95th
percentile. Results were adjusted for the covariates listed for model 2 in table 2 plus Hg / Se
levels (continuous in natural logarithm form) for (a) / (b).
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Table 3
Joint modification by toenail Se and Hg levels of the association between LCω3PUFA intake and incidence of
hypertension, CARDIA study, 1985 to 2005*
No. of participants No. of Events HRs (95%CIs)
Total cohort 3883 852 0.81 (0.73, 0.90)†
0.82 (0.74, 0.91)‡
Se<0.84, Hg ≥ 0.21 942 204 0.90 (0.78, 1.04) †
Hg <0.21 1003 278 0.78 (0.65, 0.95) †
Se≥0.84, Hg ≥ 0.21 1003 186 0.79 (0.66, 0.96) †
Hg <0.21 935 184 0.76 (0.58, 0.99) †
CARDIA, Coronary Artery Risk Development in Young Adults; CI, Confidence interval; HR, Hazard ratio; Hg, mercury; LCω3PUFA, long-chain
omega-3 polyunsaturated fatty acid; Se, selenium.
*
HRs and 95% CIs were calculated based on a standard deviation (0.19g/d) increment in LCω3PUFA intake by using Cox proportional hazards
regression analysis.
†
The model was adjusted for the covariates listed for model 2 in table 2.
‡
Additionally adjusted for Se and Hg levels, both as binary variables (above vs. below median)
§
Se median: 0.84 (μg/g); Hg median: 0.21 (μg/g).
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